A new study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) at the Jewish General Hospital, Princess Margaret Cancer Center and MIT has identified a novel approach to combat aggressive breast cancers by retraining neutrophils, the body’s first responders, to directly kill tumor cells. This research offers new hope for patients with breast cancers that do not respond well to existing immunotherapies.
This article was originally published on MedicalXpress.com
